IL32 and rheumatoid arthritis: Given the previously indicated relation between the promoter SNP and HDLc levels in RA patients and the new findings of the functional effect of the promoter SNP on cytokine production and response to treatment, these data show a possible additional role of IL-32 and its promoter SNP in RA.